NEWCASTLE UPON TYNE, England, October 1, 2012 /PRNewswire/ -- Leica Biosystems announces the availability of the Novocastra™ HD menu for breast pathology, the first portfolio of independently qualified* antibodies from the new Novocastra HD range. Together with the FDA approval...
Medication Management, Wound Care Part of New Normal for Caregivers WASHINGTON, Oct. 1, 2012 /PRNewswire-USNewswire/ -- Today, AARP Public Policy Institute (PPI) and the United Hospital Fund (UHF) released a new report that finds 46 percent of family caregivers perform medical and...
OAK BROOK, Ill., Oct. 1, 2012 /PRNewswire-USNewswire/ -- Members of Lions clubs from around the country will join White House staff and United States government agency officials at the White House in Washington, D.C., Oct. 2 to recognize Lions club...
SAN DIEGO, Oct. 1, 2012 /PRNewswire-iReach/ -- Dermatology Laser Center of San Diego is pleased to announce it has new, modern state of the art eBx radiation therapy in its offices. This new form of radiation therapy allows patients to...
SUNNYVALE, Calif., Oct. 1, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing new treatments for brain-related disorders including Parkinson's disease and Traumatic Brain Injuries (TBI) centered on its proprietary anti-apoptotic therapeutic protein known as MANF, today...
MINNEAPOLIS, Oct. 1, 2012 /PRNewswire/ -- Today marks the fifth anniversary of Minnesota's Freedom to Breathe Act, the law that made Minnesota's bars, restaurants and workplaces smoke-free. The landmark health legislation, which received strong bipartisan support, was enacted on October 1,...
SAN DIEGO, Oct. 1, 2012 /PRNewswire/ -- Receptos Inc. today announced that the company is scheduled to present the Featured Presentation at the 10th Annual Discovery on Target Conference at 8:40 a.m. EDT today at the Copley Marriott Hotel in...
NEW YORK, Oct. 1, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that Dr. Hagop Kantarjian, MD has joined the Company's Clinical Advisory Board. Dr. Kantarjian who heads the largest leukemia service...
